Method and composition for selectively inhibiting melanoma

Details Method and composition for selectively inhibiting melanoma Method and composition for selectively inhibiting melanoma

2002-12-12

2008-08-19

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S569000, C514S640000

Reexamination Certificate

active

07414042

ABSTRACT:
Compositions and methods are disclosed for treating melanoma wherein a betulinic acid derivative is the active compound in the composition to be administered. The compositions are optionally applied topically is inserted therefor.

REFERENCES:
patent: 5468888 (1995-11-01), Bouboutou et al.
patent: 5658947 (1997-08-01), DasGupta et al.
patent: 2003/0153538 (2003-08-01), Kuno et al.
patent: 1 95 32 006 (1997-03-01), None
patent: 542622 (1993-05-01), None
patent: WO 94/26725 (1994-11-01), None
patent: WO 95/04526 (1995-02-01), None
patent: WO 96/29068 (1996-09-01), None
patent: WO 96/39033 (1996-12-01), None
patent: WO 00/46235 (2000-08-01), None
patent: WO 00/59492 (2000-10-01), None
patent: WO 02/09719 (2002-02-01), None
Pisha et al., Nature Medicine (1995), 1(10), 1046-51 (abstract).
FASEB Journal, (1995) 9/8 (573).
Batta et al.,Phytochemistry, 12, 214-16 (1973).
Otsuka et al.,Chem. Pharm. Bull.(Tokyo), 29(11), (Nov. 1981).
Konoshima et al.,J. Nat. Prod.,1167-70 (1987).
Rajaram et al.,Indian Drugs, 25, 211-12 (1988).
Maurya et al.,Fitoterapia, IX, No. 5, pp. 468-469 (1989).
Patent Abstracts of Japan, vol. 013, No. 399, (Sep. 1989).
Yasukawa et al.,Oncology, 48, pp. 72-76 (1991).
Ryu et al.,Archives of Pharm. Research(Seoul), 17(5), 375-377 (1994).
Fujioka et al.,J. Nat. Prod.,57, 243-7 (1994).
Yasukawa et al.,Phytomedicine, 309-13 (1995).
Del Carmen et al.,Planta Medica, 61/2, 182-185 (1995).
Kashiwada et al.,J. Med. Chem.,39, 1016-17 (1996).
Nagourney et al.,Proc. Annu. Meet. Am. Assoc. Cancer Res.,37:A2724 (1996).
Evers et al.,J. Med. Chem.,39, 1056-68 (1996).
Bogenrieder et al.,Proc. Annu. Meet. Am. Assoc. Cancer Res.,38:A1458 (1997).
Manez et al.,European Journal of Pharmacology, vol. 334, No. 1, 103-105 (Sep. 1997).
Miles et al.,J. Pharm. Sci.,63(4), 613-15 (1974).
Miles et al.,J. Pharm. Sci.,65(2), 284-285 (1978).
Kingston et al.,J. Nat. Prod.,41(5), 499-500 (1978).
Kim et al.,Biorg. Med. Chem. Lett.,8(3), 1707-1712 (1998) (Abstract only).
Jeong et al.,Biorg. Med. Chem. Lett.,9(8), 1201-1204 (1999).

Affiliated with

Also associated with

Rating

Method and composition for selectively inhibiting melanoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for selectively inhibiting melanoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for selectively inhibiting melanoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4003284